Intravenous amoxicillin-sulbactam against Escherichia coli: optimizing the dose, component ratio and infusion time
C Bantar1, L Fernandez Canigia, M A Berger
1Laboratorio Domingo I Nanni (Paraná), Hospital Alemán, Buenos Aires, Argentina. cbantar@arnet.com.ar
Abstract:
Amoxicillin-sulbactam (AMX-SUL) is an aminopenicillin/beta-lactamase inhibitor combination currently available in 29 countries which may be a suitable option for treating intra-abdominal infections. the aim of this study was to identify the optimal dose and ratio between components of this formulation through an ex-vivo human pharmacodynamic model against Escherichia coli. Four volunteers were randomized to receive alternatively a single dose of AMX-SUL infused either over 30 min or 3h in the following ratios (g/g): 1/0.5; 1/1, 2/0.5 and 0/2. time-kill studies were performed with the 0-, 0.5-, 2-, 4-, 6- and 8-h post-dosing sera against E. coli ATCC 25922 (AMX MIC, 2 microg/ml; AMX-SUL MIC, 2 microg/ml) and E. coli ATCC 35218 (AMX MIC, 1024 microg/ml; AMX-SUL MIC, 4-8 microg/ml). AMX-SUL 1g/0.5 g infused over 30 min was only active at 0.5 h after dose, being inferior to both AMX-SUL 1g/1g and AMX-SUL 2g/0.5 g against E. coli ATCC 25922, for which the 2h post-dose serum proved active. When tested against E. coli ATCC 35218, AMX-SUL 1g/0.5 g and AMX-SUL 2g/0.5 g were active only at 0.5 h post-dose, whereas AMX-SUL 1g/1g showed bactericidal activity 0.5h post-dose and was able to inhibit bacterial growth 2 h post-dose. When infused over 3h, the antimicrobial activity of AMX-SUL was better than the 30-min infusion. Moreover, AMX-SUL 1g/1g was able to inhibit, and kill to some extent, the E. coli ATCC 25922 strain at 4h post-dose (i.e. 67% and 50% of a 6- and 8-h dosing interval, respectively). The present study suggests that 1g/1g is the best formulation for AMX-SUL against E. coli. The infusion over 3h optimizes its pharmacodynamic profile, as well as that of the 1g/0.5g combination. These findings encourage the performance of clinical trials to assess the efficacy of this combination, given as an extended infusion, in the treatment of community-acquired intra-abdominal infections.
Insights
The optimal amoxicillin-sulbactam (AMX-SUL) formulation for treating E. coli infections is 1g/1g, especially when infused over 3 hours. Extended infusion enhances AMX-SUL
Area of Science:
- Pharmacology
- Microbiology
- Infectious Diseases
Background:
- Amoxicillin-sulbactam (AMX-SUL) is an antibiotic combination used for intra-abdominal infections.
- Optimizing AMX-SUL dosage and ratio is crucial for effective treatment against resistant bacteria like Escherichia coli.
Purpose of the Study:
- To determine the optimal dose and ratio of amoxicillin-sulbactam (AMX-SUL) components.
- To evaluate the ex-vivo pharmacodynamic activity of AMX-SUL against Escherichia coli using a human pharmacodynamic model.
Main Methods:
- Four volunteers received single doses of AMX-SUL with varying ratios (1/0.5, 1/1, 2/0.5 g/g) and infusion times (30 min or 3h).
- Time-kill studies were conducted using post-dosing sera against two strains of E. coli with different susceptibility profiles.
- Minimum Inhibitory Concentrations (MICs) for amoxicillin (AMX) and AMX-SUL were determined for each E. coli strain.
Main Results:
- The 1g/1g ratio infused over 3 hours demonstrated superior and prolonged antimicrobial activity against both E. coli strains compared to other ratios and infusion times.
- Extended 3-hour infusion of AMX-SUL (1g/1g and 1g/0.5g) significantly improved its pharmacodynamic profile.
- AMX-SUL 1g/1g infused over 3 hours showed sustained bactericidal activity up to 4 hours post-dose against E. coli ATCC 25922.
Conclusions:
- The 1g/1g formulation of amoxicillin-sulbactam is suggested as the optimal ratio for treating E. coli infections.
- Extended infusion over 3 hours enhances the pharmacodynamic activity of AMX-SUL, making it more effective.
- Clinical trials are recommended to validate the efficacy of extended-infusion AMX-SUL for community-acquired intra-abdominal infections.
Related Concept Videos
Estimation of k and VD of Aminoglycosides
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Dosage Interval and Administration Route: Determination Methods
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Pharmacodynamic Models: Overview
One-Compartment Model: IV Infusion
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...

